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Purpose: The aim of this study was to evaluate the prognostic significance of the ratio between metastatic and examined 
lymph nodes (LNs) in patients with stage III rectal cancer. Methods: A review was made of 175 (male, 98) patients with stage 
III rectal cancer of R0 resection. LN disease was stratified both by the American Joint Committee on Cancer/International 
Union Against Cancer nodal classification (pN) and by quartiles of the lymph node ratio (LNR). Disease-free survivals (DFS) 
were made using Kaplan-Meier curves and assessed by the log rank test and multivariate analysis was performed using the 
Cox proportional hazards model. Results: Patients ranged in age from 29 to 83 (median, 60) years with median follow-up of 
47 months (range, 13 to 181 months). months. There was a significant correlation between the number of metastatic LNs and 
the LNR (r = 0.8681, P ＜  0.0001). Cut-off points of LNR quartiles best to separate patients with regard to 5-year DFS were be-
tween quartile 2 and 3, and between 3 and 4 (LNR1, 2, and 3); the 5-year DFS according to such stratification was 89.6%, 
55.8%, and 18.2% in LNR1, 2, and 3, respectively (P ＜ 0.0001). Cox model identified the LNR as the most significant in-
dependent prognostic covariate; LNR2 showed 3.6 times (95% confidence interval [CI], 1.682 to 7.584; P = 0.0009) and LNR3, 
18.7 times (95% CI, 6.872 to 50.664; P ＜  0.0001) more risky than LNR1. Conclusion: This study suggests that ratio-based LN 
staging, which reflects the number of LNs examined and the quality of LN dissection, is a simple and reliable system for 
prognostic LN stratification in patients with stage III rectal cancer. 
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INTRODUCTION
En-bloc surgical resection based on the concept of total 
mesorectal excision (TME) remains the mainstay of cura-
tive treatment options for rectal carcinoma [1,2]. Identifi-
cation of lymph node (LN) metastasis is one of the most 
important pathologic predictors associated with both lo-
cal recurrence and disease-specific survival [3,4].
In the American Joint Committee on Cancer and the 
International Union Against Cancer (AJCC/UICC) tumor, 
node, metastasis (TNM) staging system, the classification 
of LN metastasis (pN) in patients with stage III colorectal 
cancer is established on the basis of the number of LN in-
volved (pN1, metastatic node ≤  3; pN2, metastatic node 
≥ 4) [5]. This number-based LN classification, however, 
may have inherent limits. As the number of LNs examined  
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increases, accuracy in staging and long-term survival is 
improving [6-8]. Many studies have been performed to de-
termine the optimal number of LNs to be examined to 
stage nodal disease accurately [8-10], but results showed a 
high degree of variability, and no definite consensus on the 
number of LNs to be examined for accurate staging has yet 
been made. Paradoxically, moreover, the number of meta-
static LN(s) may increase when more LNs are retrieved in 
stage III disease. To overcome these ambiguities asso-
ciated with simple number-based LN classification, more 
recent evidences emphasize the importance of ratio-based 
LN staging as a predictor of survival and this metastatic 
LN ratio (LNR), which considers the number of both meta-
static and retrieved LNs, has been suggested to be an im-
portant prognostic factor in colon and rectal carcinoma 
[11-13]. This nodal classification may obviate the risk of 
over-staging or under-staging incurred in the pN classi-
fication used in the TNM staging system and may provide 
more accurate prognostic information from LN involve-
ment.
The aim of this study was to discover whether the ratio 
between metastatic and examined LNs can predict surviv-
al in patients with stage III rectal carcinoma.
METHODS
From the database of patients who underwent surgical 
resection for colorectal cancer under the care of the 
Department of Surgery, Dong-A University Medical 
Center from 1996 through 2002, stage III rectal carcinomas, 
where a radical R0 resection was performed, were re-
viewed. All patients underwent surgery according to the 
principles of TME, as previously described [14]. Postop-
erative chemoradiation therapy (mean radiation dose of 
50.4 Gy with concurrent chemotherapy using the Mayo 
Clinic regimen) for stage III rectal carcinoma were stand-
ard protocols for adjuvant treatment modality in our 
institution. To minimize bias associated with data analy-
ses, patients who received neoadjuvant chemoradiation 
therapy or who received no adjuvant therapy were not 
considered in this study. Other exclusions included 3 pa-
tients with familial adenomatous polyposis, 4 with syn-
chronous tumors, 8 in whom less than 7 LNs were exam-
ined (as recommended by 2002 edition of AJCC/UICC can-
cer staging system), and 21 patients with inadequate fol-
low-up data. A total of 175 (male, 98) patients were eligible 
for this retrospective study. 
LN disease was stratified by both AJCC/UICC nodal 
staging system (pN) and by quartiles of the LNR. The LNR 
was defined as the number of metastatic LNs divided by 
the number of retrieved LNs for each patient. We, herein, 
interpreted oncologic outcome in terms of disease-free 
survivals (DFS) rather than overall survivals (OS) in order 
to avoid inherent bias associated with different inhomoge-
neous treatment options of postoperative metastatic or re-
current diseases, including surgeries and diverse chemo-
therapeutic modalities. Five-year DFS were made using 
Kaplan-Meier curves and assessed by the log rank test. To 
compare the prognostic value of LNR with other factors, 
multivariate analysis was performed using the Cox pro-
portional hazards model in forward stepwise regression. 
For statistical analysis, data were entered into a spread-
sheet program and subsequently imported into statistic 
programs (Prism ver. 4, GraphPad Software Inc., San 
Diego, CA, USA; SAS ver. 8.2, SAS Institute Inc., Cary, NC, 
USA). Correlation between the number of metastatic LNs 
and LNR was analyzed by the Pearson correlation coeffi-
cient. Survival curves were calculated using the Kaplan- 
Meier method and analyzed by the log-rank test. To assess 
the relative prognostic value of covariates associated with 
5-year DFS, multivariate analyses were carried out using 
the Cox proportional hazard regression model. A P-value 
of less than 0.05 was considered statistically significant.
RESULTS
Patients ranged in age from 29 to 83 years (median, 60 
years) with median follow-up period being 47 months 
(range, 33 to 181 months). A total of 3,118 LNs with a me-
dian nodal yield of 16 (range, 8 to 55) per specimen were 
retrieved and examined, of which 911 (median, 3; range, 1 
to 30) LNs proved to be metastatic. The median of the LNR 
in the present study was 0.21 (mean, 0.30; range, 0.02 to 
0.97). During the follow- up, 69 patients experienced dis-Sang-Min Lee, et al.
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Table 1. Lymph node ratio (LNR) and clinicopathologic charac-
teristics
Variable LNR P-value
Age (yr) 0.1839
　＜  60 0.32 ± 0.26
　≥  60 0.27 ± 0.25
Gender 0.2418
　Male 0.31 ± 0.26
　Female 0.27 ± 0.24
Tumor grade  ＜  0.0001
　Well differentiated  0.22 ± 0.20
　Moderately differentiated 0.32 ± 0.26
　Poorly differentiated 0.58 ± 0.27
　Mucinous 0.51  ±  0.27
pT classification 0.0023
　pT1-2 0.14 ± 0.12
　pT3-4 0.32  ±  0.26
pN classification  ＜  0.0001
　pN1 0.14 ± 0.08
　pN2 0.49 ± 0.25
Lymphovascular invasion 0.0002
　Negative 0.24  ±  0.21
　Positive 0.38  ±  0.28
Preoperative serum CEA (ng/mL) 0.4983
　＜  5.0 0.29 ± 0.25
　≥  5.0 0.32  ±  0.25
Values are presented as mean ± SD.
CEA, carcinoembryonic antigen.
Fig. 2. Kaplan-Meier survival curves for 4 groups based on quartiles
of the distribution of metastatic lymph node ratio. Differences in 
5-year disease-free survivals between quartile (Q) 2 and 3 and 
between 3 and 4 were statistically significant (P ＜  0.0001, each).
Fig. 1. The correlation between the metastatic lymph node ratio and 
number of lymph node metastases. The lymph node ratio is closely 
correlated with the number of lymph node metastases (Pearson 
correlation coefficient, 0.8681; P ＜  0.0001).
ease relapse; 13 local recurrences, 50 distant metastases, 
and 6 both local recurrence and distant metastases. The 
mean LNRs in each mode of relapse were not different 
statistically (0.35 vs. 0.49 vs. 0.59; P = 0.151). Table 1 shows 
the correlation between the LNR and clinicopathologic 
characteristics; the LNR was significantly higher in cases 
with lymphovascular invasion (P = 0.0002) and was sig-
nificantly correlated with grade of differentiation (P ＜ 
0.0001), depth of invasion (P = 0.0023), and pN classi-
fication (P ＜ 0.0001). Furthermore, a significant correla-
tion, as shown in Fig. 1, was found between the number of 
metastatic LN(s) and the LNR (Pearson correlation co-
efficient, 0.8681; 95% confidence interval [CI], 0.8262 to 
0.9005; P ＜  0.0001) and a simple linear regression demon-
strated that the LNR increases 0.0395 units as the number 
of metastatic LN increases by one (95% CI, 0.0362 to 0.0429; 
P ＜  0.0001). 
Overall 5-year DFS in this analysis was 60.2%. Patients 
were stratified into four groups based on quartiles of the 
LNR to explore if a specific cutoff could affect oncologic 
outcome. Based on Kaplan-Meier plots (Fig. 2), cutoff 
points of quartiles of the LNR considered the best in-
dicator for separating patients with regards to 5-year DFS 
were between quartile 2 and 3 (95% CI, 0.0594 to 0.3398; P 
＜  0.0001), and between 3 and 4 (95% CI, 0.1629  to 0.5059; 
P ＜  0.0001); they were restaged into 3 subgroups (LNR1, 
2, and 3; Table 2). The 5-year DFS according to this 
LNR-based staging was 89.6%, 55.8%, and 18.2% for 
LNR1, LNR 2, and LNR3, respectively (P ＜  0.0001, Fig. 3). 
Table 3 demonstrates that LNR obviously discloses onco- 
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Table 2. Lymph node ratio (LNR) categories
          Category  Stratification HR 95% CI P-value
LNR (quartile) 0.02-0.11
0.12-0.21 0.38 0.5640-11.04 0.2282
0.22-0.39 12.34 0.0594-0.3398  ＜0.0001
0.40-0.97 3.05 0.1629-0.5059  ＜0.0001
LNR reclassification (cutoff) 0.02-0.21
0.22-0.39 7.01 0.0428-0.2413  ＜0.0001
0.40-0.97 3.05 0.1629-0.5059  ＜0.0001
HR, hazard ratio; CI, confidence interval.
Table 3. Five-year disease-free survivals by lymph node ratio (LNR)
Overall LNR1 LNR2 LNR3 Log-rank test (P)
pN1 (n = 95) 74.0% 84.4% (75) 45.0% (20)  ＜0.0001
pN2 (n = 80) 43.8% 76.9% (13) 65.2% (23) 18.2% (44)  ＜0.0001
Log-rank test (P)  ＜  0.0001 0.3277 0.2404
Fig. 3. Kaplan-Meier survival curves for the ratio-based staging. 
Five-year disease-free survival was 89.6%, 55.8%, and 18.2% for 
lymph node ratio (LNR)1, LNR2, and LNR3, respectively (P ＜
0.0001). 
logically distinct subgroups within each AJCC/UICC pN1 
and pN2 nodal category. In pN1 category, the 5-year DFS 
of LNR1 subgroup was significantly higher than that of 
LNR2 (84.4% vs. 45%; P ＜  0.0001), and the same in pN2 
category (LNR1 vs. LNR2 vs. LNR3, 76.9% vs. 65.2% vs. 
18.2%; P ＜  0.0001). Moreover, in each LNR category, DFS 
between pN1 and pN2 was not different statistically. 
Probability of stage migration in the AJCC/UICC nodal 
classification might be inferred from the finding that 
5-year DFS of 45% for pN1 subgroup with LNR2 was less 
favorable than that of 76.9% for pN2 subgroup with LNR1, 
although statistically insignificant (P = 0.1094).
To determine independent prognostic covariates for 
5-year DFS, a multivariate analysis using the Cox propor-
tional hazard regression model was performed. Both pN 
and LNR categories were considered as a factor related to 
nodal status in this model. As shown in Table 4, LNR was 
the strongest prognostic covariate (χ
2 = 33.2977, P ＜ 
0.0001), followed by pT stage (χ
2 = 3.9933, P = 0.0457), and 
preoperative serum carcinoembryonic antigen level (χ
2 = 
3.9490, P = 0.0469). In addition, evaluation of 95% CI for the 
relative risk (hazard ratio) of relapse at each level of co-
variates also confirmed strong predictive ability of the 
LNR; LNR2 showed 3.6 times more risk of relapse than 
LNR1 (95% CI, 1.682-7.584) and LNR3, 18.7 times more 
risk than LNR1 (95% CI, 6.872-50.664). pN by the AJCC/ 
UICC classification, however, was not found to be an in-
dependent prognostic predictor in this model.
DISCUSSION
Determination of regional LN status has long been con-
sidered to be one of the most important factors in predict-
ing the likelihood of long-term survival in colon and rectal 
carcinoma. LN disease in the most recent AJCC/UICC Sang-Min Lee, et al.
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Table 4. Multivariate analysis of Cox proportional hazards model
Chi- Relative
Factor   95%  CI P-value
square risk
Age (yr) 0.0461 0.997 0.975-1.021 0.8300
Gender 1.1505 0.2834
   Male 1
   Female 1.1505 0.746 0.437-1.274 0.2834
Tumor grade 1.0226 0.7958
   Well differentiated 1
   Moderately differentiated 0.1895 0.886 0.514-1.528 0.6634
   Poorly differentiated 0.3690 0.699 0.221-2.216 0.5435
   Mucinous 0.8891 0.607 0.215-1.714 0.3457
Operative procedure 0.3622 0.5473
   APR 1
   LAR 0.3622 0.841 0.479-1.477 0.5473
pT classification 3.9933 0.0457
   pT1-2 1
   pT3-4 3.9933 7.713 1.040-57.210 0.0457
pN classification 1.9363 0.1641
   pN1 1
   pN2 1.9363 0.561 0.249-1.266 0.1641
LVI 1.4493 0.2286
   Positive 1
   Negative 1.4493 0.733 0.443-1.215 0.2286
LNR 33.2977  ＜0.0001
   LNR1 1
   LNR2 10.9795 3.572 1.682-7.584 0.0009
   LNR3 32.9731 18.660 6.872-50.664 ＜0.0001
Serum CEA (ng/mL) 3.9490 0.0469
   ＜5.0 1
   ≥5.0 3.9490 1.724 1.007-2.951 0.0469
CI, confidence interval; APR, abdominoperineal resection; LAR, 
low anterior resection; LVI, lymphovascular invasion; LNR, lymph
node ratio; CEA, carcinoembryonic antigen. 
TNM system revised in 2002 is categorized simply accord-
ing to the number of metastatic LN(s) present [5]. This cur-
rent number-based nodal staging category of the TNM 
system, however, can now be criticized for the fact that the 
number of metastatic LN(s) present may be influenced by 
the total number of LNs to be examined and thus, proba-
bility of stage migration cannot be ignored [6-10,15]. In an 
attempt to overcome these shortcomings, LNR, which de-
fines the ratio of the number of metastatic-to-total number 
of LNs, has been proposed as a potentially more informa-
tive prognostic indicator for LN status. This ratio-based 
nodal staging has been studied extensively in gastric 
cancer. Compared to the number-based AJCC/UICC clas-
sification or Japanese classification of gastric carcinoma 
[16], ratio-based nodal staging has been suggested to be a 
highly reliable staging system with a strong ability to pre-
dict oncologic outcome [17-22]. Similar results have been 
reported in other solid tumors, as well [23-25]. A sig-
nificance of the LNR relevant to oncologic prognosis in co-
lon cancer has been presented recently [11-13]. Berger et al. 
[12] analyzed data from the Intergroup 0089 trial and con-
cluded that LNR was an important prognostic factor for 
colon carcinoma and that LNR may decrease the potential 
for stage migration, which can be influenced by the num-
ber of dissected LNs. Our previous study also demon-
strated that LNR was the strongest prognostic covariate in 
node-positive colon cancer [11]. Oncologic significance of 
LNR in rectal cancer might be somewhat ambiguous in in-
terpretation because of diverse adjuvant modalities. To 
keep the homogeneity in study populations, the current 
study considered only those patients who received post-
operative chemotherapy (upper rectal cancer) or chemo-
radiation therapy (mid or lower rectal cancer). Like in co-
lon cancer, results clearly indicated that nodal staging ac-
cording to the LNR had a significant oncologic relevance 
in stage III rectal cancer. Larger-scale studies also con-
cluded that LNR was the most significant predictor of sur-
vival in patients with LN-positive rectal cancer, irre-
spective of adjuvant modalities [13,26,27].
Highly suggestive in this study are the findings in Table 
3 that LNR obviously discloses oncologically distinct sub-
groups within each AJCC/UICC pN1 and pN2 nodal cate-
gory. These results obviously show that the ratio-based 
nodal staging reflects the number of LNs examined and 
the quality of LN dissection. Considering the results of 
5-year DFS for pN1 category with LNR2 subgroup are less 
favorable than those for pN2 with LNR1 subgroup (45% 
vs. 76.9%), it may strongly imply the probability of stage 
migration in number-based pN classification. The large- 
scale study of colon cancer by Berger et al. [12] also demon-
strated a similar result; the 5-year OS for pN1 patients with 
an LNR of more than 40% is much worse (60%) than that 
for N2 patients with an LNR of less than 20% (73%). As al-
so evidenced in gastric cancer, the ratio-based nodal stag-
ing decreased the incidence of stage migration sig-
nificantly [18-20]. 
Although the LNR has been emphasized as a significant 
prognostic predictor, quantification should be followed  
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Table 5. Stepwise selection procedure using the Cox proportional 
hazard model
Case A Gender, grade, operative procedure
a), pT, pN
a), 
 LVI, CEA
a)
Case B Gender, grade, operative procedure, pT, LNR
a), 
 LVI, CEA
a)
Case C Gender, grade, operative procedure, pT
a), pN,  LNR
a),
LVI, CEA
a)
LVI, lymphovascular invasion; CEA, carcinoembryonic antigen; 
LNR, lymph node ratio.
a)Selected independent covariates.
for clinical application with validity. Contrary to the pN in 
the AJCC/UICC staging system where uniform parame-
ters are adapted for stratification, no consistent categorical 
division for prognostic stratification has been established 
in the ratio-based nodal staging, yet. In literature, the 
methodological criteria to set cutoff levels were incon-
sistent with each other and different levels of cutoff for its 
staging have been used [19-22,24]. Statistically, strat-
ification according to quartiles of ratio distribution seems 
to be sound and has been applied in diverse cancers 
[11,13,23]. To be of objective validity in this study, the au-
thor, at first, divided the ratio into 4 groups based on quar-
tiles of the distribution and then, the ratio above which the 
5-year DFS drastically decreased was established as a cut-
off point based on Kaplan-Meier plots and log-rank test. 
Noticeably, the median LNR of 0.21 in this study with 
stage III rectal cancer compares similarly with that in other 
studies for colon or rectal cancers (0.16 to 0.24) [11-13,26]. 
Further larger-scale prospective investigations may be im-
perative to establish a specific valid cutoff point of the 
LNR for prognostic stratification in clinical application.
In this study, we compared the prognostic determinant 
of the number-based pN together with the ratio-based 
LNR. To compare the predictability of pN and LNR on sur-
vival, we applied the multivariate Cox stepwise propor-
tional hazards model. To be more specific, we considered 
3 cases of models (case A, case B, and case C). Case A in-
cluded all covariates except LNR, case B all except pN, and 
finally case C included both LNR and pN as well as other 
covariates. Results are summarized in Table 5. We noted 
that the covariate pN was selected when LNR was not 
included. On the other hand, LNR, not pN, was selected 
when both were included in the final Cox regression and 
proved to be the most predictive covariate among all 
others. The similar method of multivariate analysis in re-
cent studies with rectal cancer also showed that the co-
variate AJCC/UICC pN classification was not associated 
with prognosis in any cases, whereas the LNR was the 
most powerful factor associated with overall and DFS 
rates [13,26,27]. When impact of the LNR according to the 
number of LNs examined was analyzed, the LNR was an 
independent prognostic factor for overall survival even in 
the subgroup of patients in whom fewer than 12 LNs were 
examined [27]. Therefore, nodal classification according to 
the LNR is considered a better qualified independent 
prognostic determinant than the number-based pN and 
could replace total number of metastatic LN in future stag-
ing systems. 
In conclusion, the current study suggests that the LNR 
displays a better stratification of the LN disease from an 
oncologic point of view and minimize the probability of 
stage migration compared with pN which may be influ-
enced by the number of LNs examined. The ratio-based 
LN staging can be considered a simple and reliable system 
to assess oncologic prognosis of patients who underwent a 
potentially curative radical resection for LN-positive rec-
tal cancer. 
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